Metraipolis › archive › dc_cc4df9e3ef05

Use of Clinical Trial Characteristics to Estimate Costs of New Drug Development — Europe PMC PMID:39761045

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/39761045
DOI
10.1001/jamanetworkopen.2024.53275
License (as archived)
solo-consultazione
Archived
2026-10-07T17:57:04.594Z
SHA-256 of the archived text
667d66edf3e2260e597e6d5482556ca7bdbdf5fe55b6195a09b9d1cd0dc1aa35
Stable URL of this page
https://metraipolis.com/documento/dc_cc4df9e3ef05

How to cite

Use of Clinical Trial Characteristics to Estimate Costs of New Drug Development — Europe PMC PMID:39761045 — Europe PMC (en), https://europepmc.org/article/MED/39761045 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cc4df9e3ef05 (Metraipolis archive dc_cc4df9e3ef05, sha256 667d66edf3e2260e597e6d5482556ca7bdbdf5fe55b6195a09b9d1cd0dc1aa35)
BibTeX
@misc{dccc4df9e3ef05,
  title = {Use of Clinical Trial Characteristics to Estimate Costs of New Drug Development — Europe PMC PMID:39761045},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/39761045},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cc4df9e3ef05; sha256 667d66edf3e2260e597e6d5482556ca7bdbdf5fe55b6195a09b9d1cd0dc1aa35},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/39761045. Agents can read the archived copy with the MCP tool read_document.